ArticleDiscover oncology2025
Isorhamnetin inhibits cholangiocarcinoma proliferation and metastasis via PI3K/AKT signaling pathway.
Zhiguo Tan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleDiscover oncology2025
Zhiguo Tan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.